首页> 外文OA文献 >EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies

【2h】

EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies

机译：与T细胞恶性肿瘤患者的抗CD2单克隆抗体，Siplizumab的eBV相关淋巴抑制性疾病使抗CD2单克隆抗体的治疗复杂化

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Deirdre OMahony; John C. Morris; Maryalice Stetler-Stevenson; Helen Matthews; Margaret R. Brown; Thomas Fleisher; Stefania Pittaluga; Mark Raffeld; Paul S. Albert; Dirk Reitsma; Karen Kaucic; Luz Hammershaimb; Thomas A. Waldmann; John E. Janik;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies. [J] . OMahony D, Morris JC, Stetler-Stevenson M, Clinical cancer research: an official journal of the American Association for Cancer Research . 2009,第7期

机译：T细胞恶性肿瘤患者中，EBV相关的淋巴增生性疾病使抗CD2单克隆抗体siplizumab的治疗复杂化。
2. Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas [J] . Roswarski Joseph, Roschewski Mark, Lucas Andrea, Leukemia and lymphoma . 2018,第5a6期

机译：抗CD2单克隆抗体，Siplizumab的I相剂量升级研究，具有Da-Epoch-R在侵蚀性外周T细胞淋巴瘤中
3. Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies. [J] . Langley RG, Papp K, Bissonnette R, International journal of dermatology . 2010,第7期

机译：静脉和皮下siplizumab（一种抗CD2单克隆抗体）用于治疗斑块状牛皮癣的安全性概况：两项随机，双盲，安慰剂对照研究的结果。
4. Characterization of cancer specific human monoclonal IgM antibodies produced by hybridomas derived from a patient with adult T-cell leukemia [C] . T. KAWAHARA, A. ICHIKAWA, Y. KATAKURA, Annual Meeting of the Japanese Association for Animal Cell Technology . 2002

机译：杂交瘤产生的癌症特异性人单克隆IgM抗体的表征衍生自成人T细胞白血病患者的杂交瘤
5. The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies. [D] . Koduri, Megha Pallavi. 2017

机译：嵌合抗原受体T细胞疗法对B细胞恶性肿瘤的治疗潜力。
6. Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies Immune Checkpoint Inhibitors and CAR T-Cell Therapies [O] . Ioannis Kyriakidis, Eleni Vasileiou, Claudia Rossig, 2021

机译：用靶细胞表面抗原治疗的血液无法血液恶性肿瘤儿童的侵袭性真菌疾病：单克隆抗体免疫检查点抑制剂和汽车T细胞疗法
7. Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies [O] . Ioannis Kyriakidis, Eleni Vasileiou, Claudia Rossig, 2021

机译：用靶细胞表面抗原治疗的血液无法血液恶性肿瘤儿童的侵袭性真菌疾病：单克隆抗体，免疫检查点抑制剂和汽车T细胞疗法

EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies

著录项

引文网络

相似文献

相关主题

期刊订阅